Trials / Unknown
UnknownNCT02580955
REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions
ReFlow Study, a Physician-initiated Trial Investigating the Efficacy of the LegFlow Paclitaxel-Eluting Peripheral Balloon Dilatation Catheter for the Treatment of Femoropopliteal Lesions Longer Than 15cm (TASC C&D Lesions).
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Flanders Medical Research Program · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A physician initiated trial investigating the LEGFLOW Paclitaxel-Eluting Peripheral Balloon dilatation catheter for the treatment of femoropopliteal lesions longer than 15cm. Objective: to evaluate the short-term outcome of the treatment by means of the LEGFLOW Paclitaxel-Eluting Peripheral BAlloon Dilattaion for the treatment of long femoropopliteal lesions (TASC C\&D).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LEGFLOW DCB |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2015-10-20
- Last updated
- 2018-08-13
Locations
4 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02580955. Inclusion in this directory is not an endorsement.